IRIS Institutional Research Information System - OPENBS Open Archive UniBS

FRANCESCHINI, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.580
EU - Europa 11.438
AS - Asia 10.827
SA - Sud America 2.057
Continente sconosciuto - Info sul continente non disponibili 561
AF - Africa 272
OC - Oceania 26
AN - Antartide 1
Totale 43.762
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.154
IT - Italia 5.143
SG - Singapore 3.838
CN - Cina 3.262
BR - Brasile 1.700
UA - Ucraina 1.485
HK - Hong Kong 1.248
DE - Germania 1.202
VN - Vietnam 730
FR - Francia 669
FI - Finlandia 608
GB - Regno Unito 543
BD - Bangladesh 519
RU - Federazione Russa 422
TR - Turchia 385
IE - Irlanda 375
IN - India 256
PL - Polonia 208
CA - Canada 201
NL - Olanda 157
SE - Svezia 136
AR - Argentina 128
MX - Messico 117
ZA - Sudafrica 92
ES - Italia 91
IQ - Iraq 89
JP - Giappone 81
AT - Austria 66
PK - Pakistan 62
EC - Ecuador 50
ID - Indonesia 50
BE - Belgio 49
VE - Venezuela 47
CO - Colombia 40
SA - Arabia Saudita 40
MA - Marocco 33
CZ - Repubblica Ceca 31
EG - Egitto 29
JM - Giamaica 28
NG - Nigeria 28
UZ - Uzbekistan 28
JO - Giordania 27
LT - Lituania 27
AE - Emirati Arabi Uniti 25
EE - Estonia 25
PY - Paraguay 25
RO - Romania 22
AU - Australia 21
CL - Cile 21
AZ - Azerbaigian 20
HR - Croazia 20
CH - Svizzera 19
IL - Israele 19
KE - Kenya 19
PE - Perù 18
PH - Filippine 18
TN - Tunisia 18
UY - Uruguay 17
KZ - Kazakistan 16
NP - Nepal 16
PT - Portogallo 16
DZ - Algeria 15
EU - Europa 14
CR - Costa Rica 13
HN - Honduras 13
SK - Slovacchia (Repubblica Slovacca) 13
AL - Albania 12
GR - Grecia 12
IR - Iran 12
TT - Trinidad e Tobago 12
MK - Macedonia 11
KG - Kirghizistan 10
LU - Lussemburgo 10
BG - Bulgaria 9
LB - Libano 9
PA - Panama 8
TH - Thailandia 8
BO - Bolivia 7
HU - Ungheria 7
MY - Malesia 7
NI - Nicaragua 7
NO - Norvegia 7
PS - Palestinian Territory 7
RS - Serbia 7
BA - Bosnia-Erzegovina 6
CI - Costa d'Avorio 6
ET - Etiopia 6
GE - Georgia 6
GT - Guatemala 6
LV - Lettonia 6
UG - Uganda 6
AM - Armenia 5
BH - Bahrain 5
BY - Bielorussia 5
CY - Cipro 5
DK - Danimarca 5
KR - Corea 5
AO - Angola 4
BB - Barbados 4
DO - Repubblica Dominicana 4
Totale 43.143
Salva come PNG Salva come JPEG
Città #
Singapore 2.009
Ashburn 1.610
Fairfield 1.572
Hong Kong 1.245
Woodbridge 1.143
Jacksonville 1.093
San Jose 1.035
Houston 838
Beijing 768
The Dalles 762
Cambridge 625
Seattle 605
Ann Arbor 587
Wilmington 578
Princeton 552
New York 528
Chandler 477
Los Angeles 460
Milan 450
Helsinki 371
Nanjing 352
Lauterbourg 311
Dublin 305
Istanbul 304
Dallas 283
Columbus 282
Chicago 267
Rome 265
Ho Chi Minh City 247
Brescia 237
Munich 226
Warsaw 184
Buffalo 176
Hanoi 155
Moscow 152
São Paulo 146
Council Bluffs 131
Des Moines 130
Redondo Beach 127
Nanchang 122
San Francisco 121
Florence 118
San Diego 116
Shanghai 109
Santa Clara 106
Hebei 105
Shenyang 105
Changsha 97
London 96
Tianjin 88
Salt Lake City 87
Turin 78
Turku 74
Jinan 73
Tokyo 73
Bologna 68
Nuremberg 66
Verona 66
Jiaxing 63
Trieste 63
Brooklyn 62
Orem 61
Rio de Janeiro 59
Lancaster 58
Atlanta 57
Hangzhou 56
Phoenix 56
Chennai 55
Bergamo 54
Frankfurt am Main 52
Johannesburg 52
Toronto 50
Montreal 48
Brussels 45
Genoa 45
Mexico City 45
Dearborn 43
Denver 43
Guangzhou 41
Belo Horizonte 40
Amsterdam 39
Elk Grove Village 38
Tampa 38
Naples 36
Kunming 35
Stockholm 34
Udine 34
Dhaka 33
Manchester 33
Ningbo 33
Romola 33
Vienna 33
Mumbai 32
Padova 32
Lappeenranta 30
Poplar 30
Zhengzhou 30
Charlotte 29
Catania 28
Palermo 28
Totale 25.162
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.390
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.851
Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis 708
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 487
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 244
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 223
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 217
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 216
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 214
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 207
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 204
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 197
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 197
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 197
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 192
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 190
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 187
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 186
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 184
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 182
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 181
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 180
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 180
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 178
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 178
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 175
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 174
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 172
Antiphospholipid antibodies mediate autoimmunity against dying cells. 171
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 170
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 170
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 169
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 169
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 164
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 164
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 164
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality 163
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 159
The clinico-serological spectrum of overlap myositis 158
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 157
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 157
Autoimmune polyendocrine Syndromes 156
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 156
Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis 155
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 155
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 155
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 153
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 151
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 150
Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins 150
Evaluation of Ascending Aorta Wall in Rheumatoid Arthritis by Tissue and Strain Doppler Imaging During Anti-Tumor Necrosis Factor-α Therapy 150
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. 148
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 147
Severe skin involvement in type II cryoglobulinemia successfully treated with thalidomide 146
Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus 145
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 144
Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. 143
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 142
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. 141
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 141
Anti-Ro/SSA and La/SSB antibodies 141
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase 141
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. 140
A prospective evaluation of endothelial dysfunction in systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results 139
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 139
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 138
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 138
Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: The positive experience of a national multicentre study 137
Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients 137
Bridging the Diagnostic Gap for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker 136
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus. 134
DECREASED TITER OF ANTI-CCP ANTIBODIES AND RHEUMATOID FACTOR AND REDUCTION OF POSTSWITCH MEMORY B CELLS AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS 134
The 2016 classification criteria for primary Sjogren's syndrome: What's new? 134
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 134
METODICHE AUTOMATIZZATE PER ANTICORPI ANTINUCLEO (ANA): E' POSSIBILE SOSTITUIRE L'IMMUNOFLUORESCENZA INDIRETTA? 133
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 131
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 131
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 131
Incidence of antiperinuclear factor in patients with psoriatic arthritis. 130
Deforming arthropathy of the hands in Systemic Lupus Erythematosus is associated with antibodies to SS-A/Ro and to SS-B/La. 129
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 129
Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors 129
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 129
Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. 128
Belimumab decreases flare rate and hinders the expected damage progression in patients with active systemic lupus erythematosus 128
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 128
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 127
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 127
Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experience. 127
In vivo reflectance confocal microscopy features of cutaneous microcirculation and epidermal and dermal changes in diffuse systemic sclerosis and correlation with histological and videocapillaroscopic findings. 127
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 126
75-SeHCAT retention test in chronic cholestatic disease: comparison with health and effect of bile acid therapy. 126
Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference 126
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 126
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 126
Myositis autoantibodies and clinical phenotypes 125
Antiperinuclear factor in psoriatic arthropathy 124
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 124
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center 123
Antinuclear antibodies in psoriatic arthritis and its subgroups 123
Totale 20.289
Salva come PNG Salva come JPEG
Categoria #
all - tutte 210.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 210.425
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.825 0 401 140 176 164 200 201 234 193 296 272 548
2022/20232.266 341 38 51 99 194 564 47 229 384 56 139 124
2023/20242.853 150 84 228 246 134 458 134 138 667 94 107 413
2024/20257.324 117 156 125 734 678 592 568 343 675 585 1.492 1.259
2025/202613.956 1.224 1.862 1.068 1.878 1.336 929 2.057 583 767 1.147 688 417
2026/2027822 783 39 0 0 0 0 0 0 0 0 0 0
Totale 43.762